The program looks to accelerate the commercialization of discoveries from Stanford’s researchers. Northpond Labs, the research and development arm of Northpond Ventures, will fund the five-year partnership, according to a July 12 Stanford Medicine news release.
The collaboration will focus on innovative life sciences technologies such as computational biology, diagnostics, research and development solutions, biomanufacturing and therapeutics.
“This program will provide our physicians and patients with access to cutting-edge clinical research and diagnostic tools,” Robert Harrington, MD, chair of the department of medicine at Stanford Medicine. “Moreover, the collaboration with Northpond will allow scientific discoveries that come out of the program to be rapidly commercialized and made available to the broader healthcare community.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
